Vanguard Group
ARRY

Vanguard Group’s Array Biopharma Inc ARRY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-20,348,961
Closed -$943M 4206
2019
Q2
$943M Sell
20,348,961
-2,758,189
-12% -$128M 0.04% 534
2019
Q1
$563M Buy
23,107,150
+1,022,869
+5% +$24.9M 0.02% 735
2018
Q4
$315M Sell
22,084,281
-115,182
-0.5% -$1.64M 0.01% 952
2018
Q3
$337M Sell
22,199,463
-882,864
-4% -$13.4M 0.01% 1041
2018
Q2
$387M Buy
23,082,327
+1,162,399
+5% +$19.5M 0.02% 920
2018
Q1
$358M Buy
21,919,928
+200,347
+0.9% +$3.27M 0.02% 920
2017
Q4
$278M Buy
21,719,581
+1,936,270
+10% +$24.8M 0.01% 1077
2017
Q3
$243M Buy
19,783,311
+160,421
+0.8% +$1.97M 0.01% 1125
2017
Q2
$164M Buy
19,622,890
+2,629,475
+15% +$22M 0.01% 1354
2017
Q1
$152M Buy
16,993,415
+6,156,120
+57% +$55M 0.01% 1412
2016
Q4
$95.3M Buy
10,837,295
+1,072,608
+11% +$9.43M 0.01% 1650
2016
Q3
$65.9M Buy
9,764,687
+1,086,935
+13% +$7.34M ﹤0.01% 1798
2016
Q2
$30.9M Buy
8,677,752
+299,761
+4% +$1.07M ﹤0.01% 2129
2016
Q1
$24.7M Buy
8,377,991
+367,196
+5% +$1.08M ﹤0.01% 2197
2015
Q4
$33.8M Buy
8,010,795
+471,214
+6% +$1.99M ﹤0.01% 2069
2015
Q3
$34.4M Buy
7,539,581
+1,225,324
+19% +$5.59M ﹤0.01% 2044
2015
Q2
$45.5M Buy
6,314,257
+1,482,167
+31% +$10.7M ﹤0.01% 1993
2015
Q1
$35.6M Buy
4,832,090
+444,821
+10% +$3.28M ﹤0.01% 2076
2014
Q4
$20.8M Buy
4,387,269
+435,998
+11% +$2.06M ﹤0.01% 2222
2014
Q3
$14.1M Buy
3,951,271
+7,702
+0.2% +$27.5K ﹤0.01% 2347
2014
Q2
$18M Buy
3,943,569
+36,449
+0.9% +$166K ﹤0.01% 2254
2014
Q1
$18.4M Buy
3,907,120
+174,571
+5% +$821K ﹤0.01% 2225
2013
Q4
$18.7M Buy
3,732,549
+461,122
+14% +$2.31M ﹤0.01% 2194
2013
Q3
$20.3M Sell
3,271,427
-535,764
-14% -$3.33M ﹤0.01% 2106
2013
Q2
$17.3M Buy
+3,807,191
New +$17.3M ﹤0.01% 2116